Development of radiolabeling methods for the in vivo tracking of immune cells during adoptive cell therapy
Bidragets beskrivning
Adoptive cell therapy using cytotoxic, tumor-targeting immune cells has emerged as a promising treatment modality in select cancers. The aim of the project is to develop sensitive and quantitative nuclear molecular imaging tools for the tracking on transplanted immune cells and their progeny in a mouse model of metastatic melanoma. We propose to employ selective and fast bioorthogonal reactions to generate radiolabeled tracers based on direct labeling of transplanted cells, growth factors, and antibodies. The research will provide important tools for the monitoring of the success of ACT in living systems, and for the development of safer and more effective ACT therapies.
Visa merStartår
2018
Slutår
2023
Beviljade finansiering
Andra beslut
346122
Akademiforskarens forskningskostnader(2021)
159 997 €
320102
Akademiforskarens forskningskostnader(2018)
209 980 €
Finansiär
Finlands Akademi
Typ av finansiering
Akademiforskare
Utlysning
Övriga uppgifter
Finansieringsbeslutets nummer
318422
Vetenskapsområden
Kemi
Forskningsområden
Kemia
Identifierade teman
cancer